Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Third Quarter ended September 30, 2016
Filing Date: October 27, 2016
This filing announces the Company's third-quarter 2016 results via an Investor News release. The financial figures and detailed results are contained in attached Exhibits 99.1 and 99.2, which are not deemed "filed" under Section 18 of the Exchange Act.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached Exhibits (Investor News and financial tables).
The Company utilizes the following non-GAAP financial measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Used to enhance understanding of financial performance and prospects.
Reconciliations between these non-GAAP measures and the most comparable GAAP measures are included in the attached Investor News and Cash Flow Statement.
Material Changes
The filing text does not disclose specific material changes, percentage growth, or declines compared to the prior comparable period. Investors must refer to the attached Exhibits for comparative data.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures provides consistency and comparability with prior periods and enhances the user's understanding of current performance and future prospects. These measures are not intended to substitute for GAAP measures.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, contingencies, or unusual items. Such details are presumed to be within the attached Investor News release.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific revenue, EBITDA, and free cash flow figures.
- Examine Exhibit 99.2 for the detailed reconciliation of non-GAAP measures to GAAP.
- Verify year-over-year growth rates and margin trends in the attached exhibits, as they are not listed in the cover letter.
- Check the attached Investor News for any updated full-year guidance or specific risk disclosures.